Drugs for Actinic Keratosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 140)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Bacitracin |
Approved, Vet_approved |
Phase 4 |
|
1405-87-4 |
10909430 |
Synonyms:
A.L. labs brand OF bacitracin zinc salt
Ak tracin
Akorn brand OF bacitracin
Ak-tracin
ALBAC 50
Altracin
Baci im
Baci RX
BACIFERM 50
BACIGUENT
Baci-im
BACIIM
Baci-RX
Bacitin
Bacitracin
Bacitracin a
Bacitracin a2a
Bacitracin akorn brand
Bacitracin dioptic brand
BACITRACIN F, 1-(N-((2-(1-AMINO-2-METHYLBUTYL)-4,5-DIHYDRO-4-THIAZOLYL)CARBONYL)-L-LEUCINE)-
Bacitracin lee brand
Bacitracin mcneil brand
Bacitracin pharmascience brand
|
Bacitracin zinc
Bacitracin zinc complex
Bacitracin, zinc
Bacitracina
Bacitracine martinet
Ciba vision brand OF bacitracin
Dioptic brand OF bacitracin
E700
Lee brand OF bacitracin
Martinet, bacitracine
McNeil brand OF bacitracin
Ocu tracin
Ocumed brand OF bacitracin
Ocu-tracin
OcuTracin
Pharma tek brand OF bacitracin
Pharmascience brand OF bacitracin
Reed and carnrick brand OF bacitracin
Topitracin
Zeba RX
Zeba-RX
Zinc bacitracin
Zinc, bacitracin
|
|
2 |
|
Mineral oil |
Approved, Vet_approved |
Phase 4 |
|
8042-47-5 |
|
Synonyms:
Food Grade Mineral Oil
Heavy Liquid Petrolatum
Heavy mineral oil
Liquid Paraffin
Liquid Petrolatum
Mineral oil
Mineral Oil (high Viscosity)
|
Mineral Oil, Heavy
Paraffin Oil
Paraffin, Liquid
Paraffinum Liquidum
Petrolatum, Liquid
White Mineral Oil
|
|
3 |
|
Prilocaine |
Approved |
Phase 4 |
|
721-50-6 |
4906 |
Synonyms:
2-(Propylamino)-O-propionotoluidide
2-Methyl-alpha-propylaminopropionanilide
2-Methyl-a-propylaminopropionanilide
2-Methyl-α-propylaminopropionanilide
alpha-N-Propylamino-2-methylpropionanilide
a-N-Propylamino-2-methylpropionanilide
ASTRA 1512
Astra 1515
Astra brand OF prilocaine hydrochloride
ASTRA-1512
ASTRA-1515
AstraZeneca brand OF prilocaine hydrochloride
Citanest
Citanest octapressin
Citanest Plain
Delvet brand OF prilocaine hydrochloride
Inibsa brand OF prilocaine hydrochloride
L-67
|
N-(2-Methylphenyl)-2-(propylamino)propanamide
NSC-40027
O-Methyl-2-propylaminopropionanilide
O-Methyl-alpha-propylaminopropionanilide
O-Methyl-a-propylaminopropionanilide
O-Methyl-α-propylaminopropionanilide
Parnell brand OF prilocaine hydrochloride
PRILOCAIN
Prilocaina
PRILOCAINE
PRILOCAÏNE
Prilocaine base
Prilocaine hydrochloride
Prilocainum
PRILOTEKAL
Propitocaine
Xylonest
Α-N-propylamino-2-methylpropionanilide
|
|
4 |
|
Menthol |
Approved, Experimental |
Phase 4 |
|
1490-04-6, 2216-51-5, 15356-60-2 |
1254 16666 165675 |
Synonyms:
(−)-(1R,3R,4S)-menthol
(-)-(1R,3R,4S)-Menthol
(−)-menthol
(-)-Menthol
(-)-Menthyl alcohol
(-)-trans-p-Menthan-cis-ol
(+)-(1S,2R,5S)-menthol
(+)-(1S,3S,4R)-menthol
(+-)-Menthol
(1a,2b,5a)-5-Methyl-2(1-methylethyl)cyclohexanol
(1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol
(1R-(1-a,2-b,5-a))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol
(1R-(1-Α,2-β,5-α))-5-methyl-2-(1-methylethyl)cyclohexanol
(1R)-(-)-Menthol
(1R,2S,5R)-(-)-Menthol
(1R,2S,5R)-Menthol
(1R,3R,4S)-(−)-menthol
(1R,3R,4S)-(-)-Menthol
(1S,2R,5S)-(+)-menthol
(1S,2R,5S)-menthol
(1Α,2β,5α)-5-methyl-2(1-methylethyl)cyclohexanol
(R)-(-)-Menthol
1-Menthol
1-Methyl-4-isopropyl-3-hydroxycyclohexane
2-Isopropyl-5-methylcyclohexanol
3-Hydroxy-P-menthane
3-P-Menthanol
3-P-Menthol
4-Isopropyl-1-methylcyclohexan-3-ol
5-Methyl-2-(1-methylethyl)cyclohexanol
5-Methyl-2-(1-methylethyl)-cyclohexanol
5-Methyl-2-propan-2-ylcyclohexan-1-ol
AQUA-COOL
AQUASOOTHE
ARJUN
CATARRH
|
D-(-)-Menthol
DERMACOOL
DL-menthol
D-menthol
FEMA NO. 2665
Fisherman's friend lozenges
HALLS
Hexahydrothymol
KARVOL
Kerasal
L-(-)-Menthol
Levomenthol
Lévomenthol
Levomentholum
Levomentol
L-Menthol
l-menthol|levomenthol
LOCKETS
MEGGEZONES
Menthacamphor
Menthol
Menthol natural
Menthol racemic
Menthol racemique
Menthol, (1alpha,2beta,5alpha)-isomer
Menthomenthol
Mentol
MUIRS
Peppermint camphor
p-Menthan-3-ol
Racementhol
Racementholum
Racementol
THERAPEUTIC MINERAL ICE
TIXYLIX DECONGESTANT INH
U.S.p. menthol
VOCALZONE
|
|
5 |
|
Hydrogen peroxide |
Approved, Vet_approved |
Phase 4 |
|
7722-84-1 |
784 |
Synonyms:
[OH(OH)]
A-101
Adeka super el
Albone
Albone 35
Albone DS
Anti-keim 50
Asepticper
Baquashock
CIX
Clarigel gold
Crestal whitestrips
Crystacide
Dentasept
Deslime LP
Dihydrogen dioxide
ESKATA
H2O2
Hioxyl
Hipox
HOOH
Hybrite
Hydrogen dioxide
HYDROGEN PEROXIDE
Hydrogen peroxide (H2O2)
Hydroperoxide
Inhibine
Lase peroxide
|
Lensan a
Magic bleaching
Metrokur
Mirasept
Nite white excel 2
NSC-19892
Odosat D
Opalescence xtra
Oxigenal
Oxydol
Oxyfull
Oxysept
Oxysept I
Pegasyl
Perhydrol
Perone
Peroxaan
Peroxclean
Peroxide, hydrogen
PEROXYL
Quasar brite
Select bleach
Superoxol
T-Stuff
Whiteness HP
Whitespeed
Xtra white
|
|
6 |
|
Hyaluronic acid |
Approved, Vet_approved |
Phase 4 |
|
9004-61-9 |
53477741 |
Synonyms:
(2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate
(2S,3S,4R,5R,6R)-3-[(2S,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
(2S,3S,4R,5R,6R)-3-{[(2S,3R,4R,5S,6R)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5,6-trihydroxyoxane-2-carboxylate
2-Acetamido-2-deoxy-b-D-gluco-hexopyranosyl-(1->4)-b-D-gluco-hexopyranuronate
2-Acetamido-2-deoxy-b-D-gluco-hexopyranosyl-(1->4)-b-D-gluco-hexopyranuronic acid
2-Acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranuronate
|
2-Acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranuronic acid
2-Acetamido-2-deoxy-β-D-gluco-hexopyranosyl-(1->4)-β-D-gluco-hexopyranuronate
2-Acetamido-2-deoxy-β-D-gluco-hexopyranosyl-(1->4)-β-D-gluco-hexopyranuronic acid
Hyaluronan
Hyaluronate
WURCS=2.0/2,2,1/[a2122a-1b_1-5][a2122h-1b_1-5_2*ncc/3=o]/1-2/a4-b1
|
|
7 |
|
Tirbanibulin |
Approved, Investigational |
Phase 4 |
|
897016-82-9 |
23635314 |
Synonyms:
Klisyri®|KX 2-391|KX-01|KX-2-391|KX2-391
KX-01
KX2-391
KX-2391
|
KX-2-391
N-Benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide
N-Benzyl-2-(5-{4-[2-(morpholin-4-yl)ethoxy]phenyl}pyridin-2-yl)ethanimidate
TIRBANIBULIN
|
|
8 |
|
Diclofenac |
Approved, Vet_approved |
Phase 4 |
|
15307-86-5, 15307-79-6 |
3033 |
Synonyms:
[2-(2,6-Dichloroanilino)phenyl]acetate
[2-(2,6-Dichloroanilino)phenyl]acetic acid
2-((2,6-Dichlorophenyl)amino)benzeneacetate
2-((2,6-Dichlorophenyl)amino)benzeneacetic acid
2-[(2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
ACOFLAM
ACOFLAM RET
ACOFLAM SR
Allvoran
Apo-Diclo
ARTHRONAC
ARTHROTEC
ARTHROTEC 50
ARTHROTEC 75
Assaren
Benfofen
CAMBIA
CAT458
CATAFLAM
Cataflam®|CGP-45840B|GP-45840|Voltaren®|Voltarol®
CGP-45840B
CLOSTERIL 100
DEFANAC
DEFANAC RETARD
DEFANAC SR
Delphimix
DEXOMON RET
DEXOMON SR
Dichlofenac
Dichlofenal
Dichronic
Diclobenin
Diclofenac
Diclofenac acid
Diclofenac potassium
DICLOFENAC SOD
Diclofenac sodium
DICLOFENAC SODIUM SALT
Diclofenac, sodium
Diclofenaco
Diclofenacum
Diclofenamate
Diclofenamic acid
DICLOFLEX
DICLOFLEX RET
DICLOFLEX SR
DICLOMAX RET
DICLOMAX SR
Diclonate p
Diclophenac
Diclo-Phlogont
Diclo-Puren
Diclord
Dicloreum
DICLOTARD 100 MR
DICLOTARD 75 MR
DICLOVOL
DICLOVOL RET
DICLOVOL SR
DICLOZIP 25
DICLOZIP 50
Dicrofenac
DIFENOR XL
DIGENAC XL 100
Dolobasan
DSG318
Duravolten
DYLOJECT
Ecofenac
ECONAC
ECONAC SR
ECONAC XL
Effekton
ENSTAR SR
ENSTAR XL
ENZED
Feloran
FENACTOL
FENACTOL RET
|
FENACTOL SR
FLAMATAK MR
FLAMRASE
FLAMRASE SR
FLEXOTARD MR
GP-45840
ISCLOFEN
ISV-205
Kriplex
LOFENSAID 25
LOFENSAID 50
LOFENSAID RET 100
LOFENSAID RET 75
MASIDEMEN
MISOFEN
MOBIGEL
MOBIGEL PAINEZE
MOTIFENE
Neriodin
Novapirina
Novo-Difenac
Novo-Difenac SR
Nu-Diclo
Orthofen
Orthophen
Ortofen
PENNSAID
Primofenac
Prophenatin
ProSorb-D
RHEUMATAC RET 75
RHUMALGAN
RHUMALGAN CR 100
RHUMALGAN CR 75
RHUMALGAN SR
RHUMALGAN XL
SLOFENAC
Sodium diclofenac
Solaraze
Solaraze T
SR 38
SR-38
Tsudohmin
VALDIC 100 RET
VALDIC 75 RET
VALENAC
Valetan
VOL458
Voldal
VOLRAMAN
VOLSAID RET 100
VOLSAID RET 75
Voltaren
VOLTAREN EMULGEL
Voltaren Ophtha
VOLTAREN OPHTHALMIC
Voltaren Rapide
VOLTAREN RET
Voltaren SR
VOLTAREN XR
VOLTARENE
VOLTARENE EMULGEL
VOLTARENE L.P.
VOLTARENE RET
VOLTAREN-XR
Voltarol
VOLTAROL 12 HOUR EMULGEL P
VOLTAROL ACTIVE
VOLTAROL EMULGEL
VOLTAROL EMULGEL P
VOLTAROL GEL PATCH
VOLTAROL OPHTHA
VOLTAROL PAIN-EZE EMULGEL
VOLTAROL RET
VOLTAROL SR
Xenid
Zorvolex
ZORVOLEX CAPSULES
|
|
9 |
|
Aminolevulinic acid |
Approved |
Phase 4 |
|
106-60-5 |
137 |
Synonyms:
5 Aminolaevulinate
5 Aminolevulinate
5-ALA
5-Amino-4-oxopentanoate
5-Amino-4-oxo-pentanoate
5-Amino-4-oxopentanoic acid
5-Amino-4-oxo-pentanoic acid
5-Amino-4-oxovalerate
5-Amino-4-oxovaleric acid
5-Aminolaevulinate
5-Aminolaevulinic acid
5-Aminolevulinate
5-Amino-levulinate
5-Aminolevulinic acid
5-Amino-levulinic acid
Acid hydrochloride, aminolevulinic
Acid, aminolevulinic
Acid, Delta-aminolevulinic
|
ácido 5-aminolevulínico
Aladerm
Aminolevulinate
Aminolevulinic acid
Amino-levulinic acid
Aminolevulinic acid hydrochloride
Bertek brand OF aminolevulinic acid hydrochloride
dALA
Delta Aminolevulinic acid
delta-ALA
delta-Aminolevulinate
delta-Aminolevulinic acid
Hydrochloride, aminolevulinic acid
Kerastick
Levulan
δ-ALA
Δ-aminolevulinate
δ-aminolevulinic acid
|
|
10 |
|
Imiquimod |
Approved, Investigational |
Phase 4 |
|
99011-02-6 |
57469 |
Synonyms:
1-Isobutyl-1H-imidazo(4,5-c)quinolin-4-amine
1-Isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline
Aldara
Aldara®|R837|S-26308|Zyclara®
Imiquimod
Imiquimod acetate
|
Imiquimodum
R 837
R-837
S-26308
ZARTRA
Zyclara
|
|
11 |
|
Salicylic acid |
Approved, Investigational, Vet_approved |
Phase 4 |
|
69-72-7 |
338 |
Synonyms:
2 Hydroxybenzoic acid
2-Carboxyphenol
2-Hydroxybenzenecarboxylate
2-Hydroxybenzenecarboxylic acid
2-HYDROXYBENZOate
2-HYDROXYBENZOIC ACID
Acid, 2-hydroxybenzoic
Acid, O-hydroxybenzoic
Acid, ortho-hydroxybenzoic
Acid, salicylic
ácido salicílico
Acidum salicylicum
Advanced pain relief callus removers
Advanced pain relief corn removers
Bazuka Extra Strength Gel®|salicylate
Clear away wart remover
Compound W
Dr. scholl's callus removers
Dr. scholl's corn removers
Dr. scholl's wart remover kit
Duofil wart remover
Duoplant
Freezone
Ionil
|
Ionil plus
K 537
K 557
O Hydroxybenzoic acid
O-Carboxyphenol
O-Hydroxybenzoate
O-Hydroxybenzoic acid
Ortho hydroxybenzoic acid
Ortho-hydroxybenzoic acid
Phenol-2-carboxylate
Phenol-2-carboxylic acid
Psoriacid-S-stift
Retarder W
Rutranex
SA
Salicylate
Salicylic acid
Salicylic acid collodion
Salicylic acid soap
Saligel
Salonil
Stri-dex
trans-Ver-sal
|
|
12 |
|
Vitamin A |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
22737-96-8, 68-26-8 |
5280382 445354 |
Synonyms:
(2E,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAEN-1-OL
(ALL-E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-2,4,6,8-NONATETRAEN-1-OL
11-CIS-RETINOL
11-cis-Vitamin a alcohol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-e)-isomer
all trans Retinol
all-trans-Retinol
ALL-TRANS-RETINYL ALCOHOL
ALL-TRANS-VITAMIN A ALCOHOL
ALPHALIN
Aquasol a
AROVIT
BETA-RETINOL
B-RETINOL
CHOCOLA A
cis-11-Retinol
|
NEPALM
NSC-122759
OLEOVITAMIN A
Retinol
RETINOL (VIT A)
RETINOL ACETATE
RETINOL PALMITATE
Retinolum
RO-A-VIT
TRANS-RETINOL
Vitamin a
VITAMIN A 1
VITAMIN A OIL
VITAMIN A SOLUBILIZED
Vitamin a1
|
|
13 |
|
Radiation-Protective Agents |
|
Phase 4 |
|
|
|
14 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
15 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
16 |
|
Anti-Infective Agents, Local |
|
Phase 4 |
|
|
|
17 |
|
Protective Agents |
|
Phase 4 |
|
|
|
18 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
19 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
20 |
|
Anesthetics, Local |
|
Phase 4 |
|
|
|
21 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
22 |
|
Retinol palmitate |
|
Phase 4 |
|
|
|
23 |
|
Viscosupplements |
|
Phase 4 |
|
|
|
24 |
|
Methyl 5-aminolevulinate |
|
Phase 4 |
|
|
|
25 |
|
Dermatologic Agents |
|
Phase 4 |
|
|
|
26 |
|
Emollients |
|
Phase 4 |
|
|
|
27 |
|
Adjuvants, Immunologic |
|
Phase 4 |
|
|
|
28 |
|
interferons |
|
Phase 4 |
|
|
|
29 |
|
Immunologic Factors |
|
Phase 4 |
|
|
|
30 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
31 |
|
Dimethyl sulfoxide |
Approved, Vet_approved |
Phase 3 |
|
67-68-5 |
679 |
Synonyms:
(CH3)2SO
(Methylsulfinyl)methane
DIMETHYL SULFOXIDE
Dimethyl sulfoxixde
Dimethyl sulfur oxide
Dimethyl sulphoxide
Dimethyl sulphur oxide
Dimethyl sulpoxide
Dimethyli sulfoxidum
Dimethyli sulphoxidum
Dimethylsulfoxid
Dimethylsulfoxide
Dimethylsulfoxyde
Diméthylsulfoxyde
Dimethylsulphinyl
Dimethylsulphoxid
Dimethylsulphoxide
Dimethylsulphoxyde
Dimetil sulfoxido
Dimetil sulfóxido
Dimetil sulphoxido
Dimexide
DMSO
DOMOSO
|
INFILTRINA
Merckle brand OF dimethyl sulfoxide
Methylsulfinylmethane
Methylsulphinylmethane
NSC-763
Research ind. corp. brand 1 OF dimethyl sulfoxide
Research ind. corp. brand 2 OF dimethyl sulfoxide
Rheumabene
Rimso
rimso 100
Rimso 50
Rimso50
Rimso-50
S(O)Me2
Sclerosol
Shire brand OF dimethyl sulfoxide
SQ-9453
Sulfinylbis(methane)
Sulfoxide, dimethyl
Sulphinylbis(methane)
Sulphoxide, dimethyl
SYNTEXAN
Zymso
|
|
32 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 3 |
|
22916-47-8 |
4189 |
Synonyms:
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
Brentan
CONOFITE
Dactarin
DERMAZOLE
DUMICOAT
Esteve brand OF miconazole
florid(nitrate)|Monistat®|R-14889
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
LORAMYC
MCZ
MICATIN
|
Miconasil nitrate
Miconazol
Miconazole
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazolum
Monistat
MONISTAT-3
MONISTAT-DERM
Nitrate, miconasil
Nitrate, miconazole
NSC-170986
Oravig
VUSION
|
|
33 |
|
Clotrimazole |
Approved, Vet_approved |
Phase 3 |
|
23593-75-1 |
2812 |
Synonyms:
(Chlorotrityl)imidazole
1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole
1-(a-(2-Chlorophenyl)benzhydryl)imidazole
1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole
1-(O-Chloro-a,a-diphenylbenzyl)imidazole
1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole
1-(O-Chlorotrityl)imidazole
1-(O-Chloro-α,α-diphenylbenzyl)imidazole
1-(Α-(2-chlorophenyl)benzhydryl)imidazole
ABTRIM
ACTAVALL
Bay b 5097
BAY-5097
Bayer brand 1 OF clotrimazole
Bayer brand 2 OF clotrimazole
CANDIDEN
Canesten
Canesten 1-day cream combi-pak
Canesten 1-day therapy
Canesten 3-day therapy
Canesten 6-day therapy
CANESTEN AF
Canesten combi-pak 1-day therapy
Canesten combi-pak 3-day therapy
Canesten cream
CANESTEN CRM COMBI
CANESTEN INTERNAL
Canesten solution
CANESTEN VC
Canesten®|Lotrimin®
Canestine
Chlotrimazole
Clotrimaderm
Clotrimaderm cream
Clotrimazol
CLOTRIMAZOLE
Clotrimazole schering brand
Clotrimazolum
Desamix F
Empecid
FB b 5097
Fem care
FemCare
FUNGEDERM
GNF-PF-3499
Gyne lotrimin
Gyne-lotrimin
Gyne-lotrimin 3
Gyne-lotrimin 3 combination pack
Gyne-lotrimin combination pack
Gyne-lotrimin3
Gyne-lotrimin3 combination pack
|
Gynix
Kanesten
Klotrimazole
Lopac-C-6019
Lotrimax
Lotrimin
LOTRIMIN (TN)
Lotrimin af
Lotrimin af cream
Lotrimin af jock-itch cream
Lotrimin af lotion
Lotrimin af solution
Lotrimin cream
Lotrimin lotion
Lotrimin solution
Lotrisone
MASNODERM
mono-Baycuten
Monobaycuten
Mycelax
Mycelex
MYCELEX (TN)
Mycelex 7
Mycelex cream
Mycelex g
Mycelex otc
Mycelex solution
Mycelex troches
Mycelex twin pack
Mycelex: mycosporinrimazole
Mycelex-7
Mycelex-7 combination pack
Mycelex-g
MYCIL GOLD
Myclo cream
Myclo solution
Myclo spray solution
Myclo-gyne
Mycosporin
Mykosporin
Neo-zol cream
NSC-257473
Otomax
Pedisafe
Prestwick_120
PRIVACOM
Rimazole
Schering brand OF clotrimazole
Tibatin
Trimysten
Trivagizole 3
Veltrim
|
|
34 |
|
Selenium |
Approved, Investigational, Vet_approved |
Phase 3 |
|
7783-07-5, 7782-49-2 |
533 |
Synonyms:
[SeH2]
Dihydrogen monoselenide
Dihydrogen selenide
H2Se
Hydrogen selenide, 75Se-labeled
Hydroselenate
Hydroselenic acid
Se(2+)
Se2+
Selane
Selanediide
Selen
|
Selenide
Selenide(2-)
Selenio
Sélénium
Selenium dication
Selenium dihydride
Selenium elemental
Selenium hydride
Selenium hydride (seh2)
Selenium ion (se2+)
Selenium metallicum
Selenium, elemental
|
|
35 |
|
Selenious acid |
Approved, Investigational |
Phase 3 |
|
14124-67-5, 7783-00-8 |
1091 |
Synonyms:
[seo(OH)2]
Acid, selenious
Acid, selenous
Selenige saeure
|
selenige Säure
Selenious acid
Selenite
Selenous acid
|
|
36 |
|
Keratolytic Agents |
|
Phase 3 |
|
|
|
37 |
|
Photosensitizing Agents |
|
Phase 3 |
|
|
|
38 |
|
Trace Elements |
|
Phase 3 |
|
|
|
39 |
|
Micronutrients |
|
Phase 3 |
|
|
|
40 |
|
Ethylene |
|
Phase 3 |
|
74-85-1 |
6325 |
Synonyms:
Acetene
Aethen
Aethylen
Athylen
Bicarburretted hydrogen
CH2=ch2
Elayl
Ethene
Ethene (9ci)
Ethene, 9ci
Ethylene
Ethylene (8ci)
|
Ethylene, compressed
Ethylene, pure
Ethylene-CMPD
Etileno
H2C=ch2
Liquid ethyene
Liquid ethylene
Olefiant gas
Plastipore
Polyethylene as med mol. wt.
R-1150
|
|
41 |
|
Antifungal Agents |
|
Phase 3 |
|
|
|
42 |
|
Salicylates |
|
Phase 3 |
|
|
|
Synonyms:
2-Hydroxybenzoate ion(1-)
2-Hydroxybenzoic acid ion(1-)
O-Hydroxybenzoate
|
O-Hydroxybenzoic acid
sal
Salicylic acid
|
|
43 |
|
Antioxidants |
|
Phase 3 |
|
|
|
44 |
|
Sodium Selenite |
|
Phase 3 |
|
|
|
Synonyms:
|
45 |
|
Sunscreening Agents |
|
Phase 3 |
|
|
|
46 |
|
Anesthetics |
|
Phase 3 |
|
|
|
47 |
|
Liver Extracts |
|
Phase 3 |
|
|
|
48 |
|
Digoxin |
Approved |
Phase 2 |
|
20830-75-5 |
3062 2724385 30322 |
Synonyms:
[<sup>3</sup>H]-digoxin
12beta-Hydroxydigitoxin
12b-Hydroxydigitoxin
12Î’-hydroxydigitoxin
AWD.pharma brand OF digoxin
Bertek brand OF digoxin
Boehringer, digoxina
Cardoxin
Cogoxin
Cordioxil
Davoxin
DGO621
Digacin
DIGAMEX
DIGAZOLAN
Digitalis glycoside
Digitek
Digitekt
Digoregen
Digossina
Digoxin
Digoxin pediatric
Digoxina
Digoxina boehringer
Digoxine
Digoxine nativelle
Digoxinum
Dilanacin
Dixina
Dokim
Dynamos
Eudigox
Glaxo wellcome brand OF digoxin
GlaxoSmithKline brand 1 OF digoxin
GlaxoSmithKline brand 2 OF digoxin
|
Hemigoxine nativelle
Homolle'S digitalin
Kern brand OF digoxin
Lanacordin
Lanacrist
LANADICOR
Lanicor
Lanoxicaps
Lanoxin
LANOXIN PEDIATRIC
Lanoxin PG
Lanoxin®
LANOXIN-125
Lanoxin-PG
Lenoxicaps
Lenoxin
Lilly brand OF digoxin
Longdigox
Mapluxin
Nativelle, digoxine
Nativelle, hemigoxine
Neodioxanin
Neo-lanicor
Novartis brand OF digoxin
NSC-95100
Proctor and gamble brand OF digoxin
R.A.N. brand OF digoxin
Roche brand OF digoxin
Rougoxin
SK-Digoxin
Stillacor
Teofarma brand OF digoxin
UDL brand OF digoxin
Vanoxin
Virco brand OF digoxin
|
|
49 |
|
Furosemide |
Approved, Vet_approved |
Phase 2 |
|
54-31-9 |
3440 |
Synonyms:
2-Furfurylamino-4-chloro-5-sulfamoylbenzoate
2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid
2-Furfurylamino-4-chloro-5-sulphamoylbenzoate
2-Furfurylamino-4-chloro-5-sulphamoylbenzoic acid
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilate
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid
4-Chloro-5-sulphamoyl-N-furfuryl-anthranilate
4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilate
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid
4-Chloro-N-(2-furylmethyl)-5-sulphamoylanthranilate
4-Chloro-N-(2-furylmethyl)-5-sulphamoylanthranilic acid
4-Chloro-N-furfuryl-5-sulfamoylanthranilate
4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid
4-Chloro-N-furfuryl-5-sulphamoylanthranilate
4-Chloro-N-furfuryl-5-sulphamoylanthranilic acid
Acetic acid potassium salt
Aisemide
Aldalix
Aldic
Aluzine
ALUZINE 20
ALUZINE 40
ALUZINE 500
Anfuramaide
Apo-frusemide
Apo-furosemide
AQUAMED
Aquarid
Aquasin
Arasemide
Beronald
Bioretic
Bristab
Bristurin
Cetasix
Depix
Desal
Desdemin
Di-Ademil
DIHYDROFLUMETHIAZIDE
dihydroflumethiazide|frusemide|Lasix®|methforylthiazidine
Dirine
Disal
Discoid
Disemide
Diucardin
Diumide-K
Diural
Diurapid
DIURESAL
Diuretic salt
Diurin
Diurolasa
Diusemide
Diusil
Diuzol
Dranex
Dryptal
Durafurid
Edemid
Edenol
Eliur
Elodrine
Endural
Errolon
Eutensin
Farsix
Finuret
Fluidrol
Fluss
Franyl
FROOP
FRUMAX
Frumex
Frumide
Frumil
Frusedan
Frusema
Frusemid
Frusemide
Frusemin
Frusenex
Frusetic
Frusid
FRUSOL
Fulsix
Fuluvamide
Fuluvamine
Furanthril
Furanthryl
Furantral
Furantril
Furanturil
Furesis
Furetic
Furex
Furfan
Furix
Furmid
Furo-basan
Furobeta
Furocot
Furodiurol
Furodrix
Furomen
Furomex
Furomide m.d.
Furo-puren
Furorese
Furosan
Furose
Furosedon
Furosemid
Furosemida
Furosemida [INN-Spanish]
Furosemide
|
Furosemide "mita"
Furosemide monohydrochloride
Furosemide monosodium salt
Furosemidu
Furosemidu [Polish]
Furosemidum
Furosemidum [INN-Latin]
Furosemix
Furoside
Furosifar
Furosix
Furoter
Furovite
Fursemid
Fursemida
Fursemide
Fursol
Fusid
Fusidic acid
Golan
Hissuflux
Hydol
Hydrenox
Hydrex
Hydro
Hydroled
Hydro-rapid
Impugan
Jenafusid
Katlex
Kofuzon
Kolkin
Kutrix
Lasemid
Lasex
Lasiletten
Lasilix
Lasix
LASIX (TN)
LASIX RET
Lasix retard
Lasix Special
Laxur
Lazix
LB-502
Leodrine
Less diur
Liside
Logirene
Lowpston
Lowpstron
Luscek
Macasirool
Marsemide
Metflorylthiazidine
METHFORYLTHIAZIDINE
Mirfat
Mita
Moilarorin
Myrosemide
Nadis
Nelsix
Neo-renal
Nephron
Nicorol
Novosemide
NSC-269420
Octan draselny
Odemase
Odemex
Oedemex
Olmagran
Osyrol
Polysquall a
Prefemin
Profemin
Promedes
Promide
Protargen
Puresis
Radisemide
Radonna
Radouna
Retep
Rodiuran
Rontyl
Rosemide
Rosis
Rusyde
Sal diureticum
Salinex
Salix
Salix (brand OF furosemide)
Salurex
Salurid
Saluron
Seguril
Selectofur
Sigasalur
Sisuril
Spirofur
Synephron
TENKOFRUSE
Transit
Trofurit
Uremide
Uresix
Urex
Urex-m
Urian
Uridon
Uritol
Urosemide
Vergonil
Vesix
Yidoli
Zafimida
|
|
50 |
|
Afamelanotide |
Approved, Investigational |
Phase 2 |
|
75921-69-6 |
16132954 16197727 |
Synonyms:
α-NDP-MSH|[Nle4,dPhe7]α-MSH|CUV-1647|CUV1647|NDP-MSH|Scenesse®
4-({1-[(1-{[1-({1-[({[6-amino-1-(2-{[1-(C-hydroxycarbonimidoyl)-2-methylpropyl]-C-hydroxycarbonimidoyl}pyrrolidin-1-yl)-1-oxohexan-2-yl]-C-hydroxycarbonimidoyl}methyl)-C-hydroxycarbonimidoyl]-2-(1H-indol-3-yl)ethyl}-C-hydroxycarbonimidoyl)-4-carbamimidamidobutyl]-C-hydroxycarbonimidoyl}-2-phenylethyl)-C-hydroxycarbonimidoyl]-2-(1H-imidazol-5-yl)ethyl}-C-hydroxycarbonimidoyl)-4-({2-[(2-{[2-({1,3-dihydroxy-2-[(1-hydroxyethylidene)amino]propylidene}amino)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1,3-dihydroxypropylidene)amino]-1-hydroxyhexylidene}amino)butanoate
AFAMELANOTIDE
CUV1647
CUV-1647
|
Melanotan 1
Melanotan I
Melanotan-1
MT-I
SCENESSE
|
|
Interventional clinical trials:
(show top 50)
(show all 317)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Topical Ingenol Mebutate Versus 5% 5-fluorouracil Versus 5% Imiquimod Versus Photodynamic Therapy in Treatment of Actinic Keratosis: a Multi-centre Randomized Efficacy and Cost-effectiveness Study |
Unknown status |
NCT02281682 |
Phase 4 |
Imiquimod;5-fluorouracil;Ingenol mebutate |
2 |
A Randomised Double-blind Parallel-group Study to Evaluate the Long-term Effects of Eryfotona AK-NMSC® Cream in the Treatment of Cancerization Field in Patients With Actinic Keratosis. |
Unknown status |
NCT01656226 |
Phase 4 |
|
3 |
A Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study to Assess the Potential Effect of Topically Applied Imiquimod Cream on Atrial Ectopy in Patients With Actinic Keratosis |
Unknown status |
NCT01413763 |
Phase 4 |
Imiquimod cream 3.75%;Placebo cream |
4 |
Comparative Intraindividual Study, About the Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between Acid Methyl Aminolevulinate Cream and Aminolevulinic Gel |
Unknown status |
NCT02647151 |
Phase 4 |
METHYLAMINOLEVULINATE HYDROCHLORIDE;AMINOLEVULINIC ACID HYDROCHLORIDE |
5 |
An Investigator-Initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses (AK) on Dorsal Hands and Forearms |
Unknown status |
NCT01229319 |
Phase 4 |
Cryotherapy alone to Left arm plus cryotherapy + imiquimod to Right arm |
6 |
A Randomized Right/Left Clinical Trial to Evaluate the Use of Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy |
Completed |
NCT00695578 |
Phase 4 |
Biafine;Polysporin |
7 |
Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical Agents |
Completed |
NCT03279328 |
Phase 4 |
Topical Steroid Ointment;Skin Barrier Moisturier |
8 |
A Comparison of the Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Density of Ablative Laser Channel in the Treatment of Actinic Keratosis |
Completed |
NCT03731988 |
Phase 4 |
lidocaine/prilocaine (5%) application;MAL application |
9 |
A Multi-center, OPen, InvEstigator Initiated Phase IV Clinical TRial to Evaluate the Efficacy and SaFety of Ingenol Mebutate Gel 0.015% on Face and Scalp & 0.05% on Trunk and Extremities in KorEan Patient With ACtinic KeraTosis (PERFECT) |
Completed |
NCT02716714 |
Phase 4 |
ingenol mebutate gel 0.015%;ingenol mebutate gel 0.05% |
10 |
Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage |
Completed |
NCT03697590 |
Phase 4 |
No curettage;Curettage |
11 |
Open-Label Safety and Pharmacokinetic Study of AldaraTM (Imiquimod) Cream, 5% for One, Two, or Three Treatment Cycles to Surface Areas Greater Than 25 cm2 With Actinic Keratosis |
Completed |
NCT00116649 |
Phase 4 |
imiquimod cream |
12 |
Vehicle-Controlled, Double-Blind Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Upper Extremities |
Completed |
NCT00115154 |
Phase 4 |
Aldara (imiquimod) cream, 5% |
13 |
Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® PDT |
Completed |
NCT01000636 |
Phase 4 |
|
14 |
Comparison of the Efficacy and Tolerability of Solaraze for 3 vs. 6 Months in Patients With Mild to Moderate Actinic Keratosis Located at the Face and Head |
Completed |
NCT00204542 |
Phase 4 |
Diclofenac |
15 |
Subject Reported Outcomes on Satisfaction, Safety and Efficacy With Luxerm® in the Field-directed Treatment of Thin or Non-hyperkeratotic and Non-pigmented Actinic Keratosis of the Face or the Scalp |
Completed |
NCT03511326 |
Phase 4 |
Methyl Aminolaevulinate 16% Cream |
16 |
A Pilot Prospective Clinical Trial to Evaluate the Efficacy and Safety of Large-Scale, Field-Directed Topical Therapy of Actinic Keratosis of the Chest With Ingenol Mebutate 0.015% |
Completed |
NCT02446223 |
Phase 4 |
Inggenol Mebutate 0.015% |
17 |
Safety and Efficacy of Ingenol Mebutate Gel 0.015% for Treatment of Actinic Keratosis on the Face in Solid Organ Transplant Recipients |
Completed |
NCT02866695 |
Phase 4 |
ingenol mebutate gel 0.015% |
18 |
Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population |
Completed |
NCT00696488 |
Phase 4 |
Fluorouracil 0.5% |
19 |
Long-term Effects of Aldara® 5% Cream and Solaraze® 3% Gel in the Treatment of Actinic Keratoses on the Face or Scalp (LEIDA) |
Completed |
NCT00777127 |
Phase 4 |
Imiquimod;Diclofenac |
20 |
A Randomized Study to Evaluate the Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization Compared to Cryotherapy |
Completed |
NCT02990221 |
Phase 4 |
Ingenol mebutate |
21 |
A Phase 4 Trial Comparing the Cumulative Incidence of SCC After Treatment With Ingenol Mebutate and Imiquimod for Multiple Actinic Keratoses on Face and Scalp. A Multi-centre, Randomised, Two-arm, Open Label, Active-controlled, Parallel Group, 36-month Trial |
Completed |
NCT01926496 |
Phase 4 |
Ingenol Mebutate Gel, 0.015%;Imiquimod Cream, 5% |
22 |
UCI 14-92 / HS#2015-1889: Phase IV Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses |
Completed |
NCT03327831 |
Phase 4 |
Aminolevulinic Acid |
23 |
A Randomised Double Blind, Placebo Controlled Study of the Efficacy of Topical Menthol for Pain Relief During Topical Photodynamic Therapy |
Completed |
NCT02984072 |
Phase 4 |
Menthol;Aqueous Cream |
24 |
Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp |
Completed |
NCT02406014 |
Phase 4 |
Ingenol Mebutate Gel, 0.015%;Diclofenac sodium gel 3% |
25 |
A Randomized, Parallel-Group, Vehicle-Controlled, Double-Blind Study of Topical Imiquimod 5% Cream Used as an Adjunct to Cryotherapy in the Management of Actinic Keratoses, With a Long-Term (1 Year) Follow-Up |
Completed |
NCT00110682 |
Phase 4 |
Imiquimod used as an adjunct to cryotherapy |
26 |
Daylight Mediated Photodynamic Therapy for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL) |
Completed |
NCT02464709 |
Phase 4 |
Aminolevulinic Acid;Methyl 5-aminolevulinate |
27 |
Long-term Effects of Aldara® 5% Cream and Solaraze® 3% Gel in the Treatment of Actinic Keratoses on the Face or Scalp With Respect to the Risk of Progression to In-situ and Invasive Squamous Cell Carcinoma |
Completed |
NCT01453179 |
Phase 4 |
Imiquimod;Diclofenac |
28 |
An Open-Label Study Assessing Subject Satisfaction With A-101 Hydrogen Peroxide Topical Solution, 40% (w/w) Treatment for Seborrheic Keratoses of the Face, Neck, and Decolletage |
Completed |
NCT03487588 |
Phase 4 |
A-101 Topical Solution |
29 |
Treatment of AKs With Daylight-PDT: Comparing Two Photosensitizers (BF-200 ALA and MAL) |
Completed |
NCT01893203 |
Phase 4 |
BF-200 ALA cream;MAL cream |
30 |
A Randomized, Open-label, Assessor-blinded, Split-face Study of Imiquimod 5% Cream Applied After Cryotherapy of Actinic Keratoses |
Completed |
NCT00774787 |
Phase 4 |
imiquimod 5% cream |
31 |
An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses |
Completed |
NCT00377273 |
Phase 4 |
fluorouracil cream 0.5% |
32 |
Prospective, Controlled and Monocentric Study to Evaluate the Effects of Topical 3% Diclofenac in 2.5% Hyaluronic Acid Gel on Tumor Metabolism in the Treatment of Actinic Keratoses in Immunocompetent and Immunocompromised Patients |
Completed |
NCT01935531 |
Phase 4 |
3% diclofenac in 2.5% hyaluronic acid gel |
33 |
A Randomized, Evaluator-blinded, Bilateral Comparison of the Treatment of Facial Actinic Keratoses Using Combination Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Different Incubation Times |
Completed |
NCT02622594 |
Phase 4 |
Aminolevulinic Acid (ALA) |
34 |
An Investigator-Initiated Study to Assess the Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses (AK) on Dorsal Hands |
Completed |
NCT02251652 |
Phase 4 |
Ingenol Mebutate |
35 |
Prospective, Randomized, Controlled, Multicenter, Two-armed, Study Comparing Daylight Photodynamic Therapy Using MAL With Cryosurgery for the Treatment and Prophylaxis of Actinic Keratoses in Photodamaged Skin of the Face |
Completed |
NCT02736760 |
Phase 4 |
Daylight photodynamic therapy using Methylaminolevulinate (MAL) |
36 |
Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial |
Completed |
NCT04875026 |
Phase 4 |
5-fluorouracil 4% (Tolak) |
37 |
Clinical and Dermoscopic Evaluation of Long-pulsed 1064 nm Nd-YAG Laser Versus Trichloroacetic Acid 20% in Treatment of Keratosis Pilaris |
Completed |
NCT04797663 |
Phase 4 |
TCA 20% |
38 |
Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream |
Completed |
NCT04842422 |
Phase 4 |
Imiquimod 3.75% Cream |
39 |
Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention: A Long-term (3 Years) Follow-up of Prospective, Randomized, Multicenter-clinical Trial |
Recruiting |
NCT03642535 |
Phase 4 |
ALA |
40 |
A Phase 4, Multi-centre, Randomized, Evaluator-blinded, Active-controlled Study to Determine the Incidence of Squamous Cell Carcinoma and Evaluate the Long-term Safety of Tirbanibulin 10 mg/g Ointment and Diclofenac Sodium 3% Gel for the Treatment of Adult Patients With Actinic Keratosis on the Face or Scalp |
Recruiting |
NCT05387525 |
Phase 4 |
Tirbanibulin (Klisyri®) 10 mg/g ointment;Diclofenac Sodium 3% Gel |
41 |
Safety and Efficacy of Photodynamic Therapy With Aminolevulinic Acid 10% Topical Gel Activated by Red Light Versus Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for the Treatment of Actinic Keratosis on the Upper Extremities: A Blinded Randomized Study |
Not yet recruiting |
NCT05359419 |
Phase 4 |
|
42 |
A Study to Investigate the Effect of Different Durations of Ameluz Application on Response to Treatment of Acral Actinic Keratoses |
Suspended |
NCT03963102 |
Phase 4 |
Ameluz |
43 |
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy |
Terminated |
NCT01203878 |
Phase 4 |
Photodynamic therapy;Imiquimod |
44 |
Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study |
Terminated |
NCT00944216 |
Phase 4 |
Salkera Emollient Foam |
45 |
Topical Imiquimod 5% Cream Therapy Versus Photodynamic Therapy With Methyl-aminolaevulinate 16% Cream of Actinic Keratoses in Organ Transplant Recipients |
Terminated |
NCT01538901 |
Phase 4 |
imiquimod 5% cream |
46 |
Phase III Comparative Study About the Use of 5% 5-fluorouracil Cream Versus Its Utilization as Agent for Sequential Superficial Peeling in the Treatment of Advanced Photoaging |
Unknown status |
NCT01405144 |
Phase 3 |
5-fluoruracil |
47 |
A RANDOMIZED, DOUBLE BLIND, MULTI-CENTER CLINICAL STUDY TO TEST THE SAFETY AND EFFICACY OF T4N5 LIPOSOME LOTION ON PATIENTS WITH XERODERMA PIGMENTOSUM IN THE PROTECTION AGAINST ACTINIC KERATOSES |
Unknown status |
NCT00002811 |
Phase 3 |
liposomal T4N5 lotion |
48 |
A Double-blind, Multicenter, Long-term Follow-up Study to Assess Recurrence of Actinic Keratosis in Subjects Treated With Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) or Vehicle Cream in the Treatment of Thin and Moderately Thick, Non-hyperkeratotic, Non-pigmented Actinic Keratosis of the Face and Scalp When Using Daylight Photodynamic Therapy (DL-PDT), for Subjects Achieving Complete Response of Treated Lesions at Final Visit in Study RD.06.SPR.112199 |
Completed |
NCT04269395 |
Phase 3 |
MAL Cream;Vehicle cream |
49 |
A Phase 3, Double-Blind, Vehicle-Controlled, Randomized, Parallel Group, Multicenter, Efficacy and Safety Study of KX2-391 Ointment 1% in Adult Subjects With Actinic Keratosis on the Face or Scalp |
Completed |
NCT03285490 |
Phase 3 |
KX2-391 Ointment 1%;Placebo |
50 |
A Randomized, Double-Blind, Phase III Multi-Center Study Evaluating the Safety and Efficacy of BF-200 ALA Versus Placebo in the Treatment of Actinic Keratosis (AK) When Using PDT |
Completed |
NCT02799082 |
Phase 3 |
Vehicle;BF-200 ALA |
|